UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-07, Vol.25 (4), p.676-684

2019

Volltextzugriff (PDF)

Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation – the surgical STER

British journal of haematology, 2011-02, Vol.152 (3), p.340-346

2011

Volltextzugriff (PDF)

Rare bleeding disorders

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-07, Vol.18 (s4), p.148-153

2012

Volltextzugriff (PDF)

Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test

Clinical and Applied Thrombosis/Hemostasis, 2017-09, Vol.23 (6), p.518-531

2017

Volltextzugriff (PDF)

Analysis of von Willebrand Disease in the “Heart of Europe”

TH open : companion journal to thrombosis and haemostasis, 2022-10, Vol.6 (4), p.e335-e346

2022

Volltextzugriff (PDF)

Comparison of Two Different Techniques Of Warfarin Dosing Determination - A Chemometrics Study

Iranian journal of pharmaceutical research : IJPR, 2019-03, Vol.18 (2), p.1010-1019

2019

Volltextzugriff (PDF)

The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones

Applied sciences, 2021-07, Vol.11 (13), p.5762

2021

Volltextzugriff (PDF)

First experience of a hemophilia monitoring platform: florio HAEMO

Research and practice in thrombosis and haemostasis, 2022-02, Vol.6 (2), p.e12685-n/a, Article e12685

2022

Volltextzugriff (PDF)

Continuous infusion of coagulation factors: current opinion

Current opinion in hematology, 2006-09, Vol.13 (5), p.308-315

2006

Volltextzugriff (PDF)

Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus

Annals of hematology, 2023-04, Vol.102 (4), p.715-727

2023

Volltextzugriff (PDF)

First case report on persistent patellar dislocation in haemophilia A patient with a factor VIII inhibitor

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-09, Vol.28 (5), p.e113-e116

2022

Volltextzugriff (PDF)

Evaluation of factor V mRNA to define the residual factor V expression levels in severe factor V deficiency

Haematologica (Roma), 2008-03, Vol.93 (3), p.477-478

2008

Volltextzugriff (PDF)

Real-World Early Treatment with Room Temperature–Stable Recombinant Factor VIIa in Hemophilia A/B and Inhibitors: SMART-7™ Post Hoc Analyses

TH open : companion journal to thrombosis and haemostasis, 2017-07, Vol.1 (2), p.e130-e138

2017

Volltextzugriff (PDF)

ASP210: a potent oligonucleotide-based inhibitor effective against TKI-resistant CML cells

American Journal of Physiology: Cell Physiology, 2024-07, Vol.327 (1), p.C184-C192

2024

Volltextzugriff (PDF)

Real-world effectiveness and safety of daratumumab, bortezomib and dexamethasone in relapsed/refractory multiple myeloma in Slovakia

Neoplasma, 2021-05, Vol.68 (3), p.626-630

2021

Volltextzugriff (PDF)

ASP210 - a Potent Oligonucleotide-Based Inhibitor for Combating Both BCR-ABL1 Dependent and Independent TKI-Resistant CML Cells

Blood, 2022-11, Vol.140 (Supplement 1), p.12995-12996

2022

Volltextzugriff (PDF)

Are all licensed haemostatic agents for haemophilia therapy accessible to patients?

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-11, Vol.28 (6), p.e256-e258

2022

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation from matched related donors for acute myeloid leukemia

Bratislava Medical Journal, 2024-01, Vol.125 (9), p.551-557

2024

Volltextzugriff (PDF)

Immune tolerance induction in the era of emicizumab – still the first choice for patients with haemophilia A and inhibitors?

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-03, Vol.28 (2), p.215-222

2022

Volltextzugriff (PDF)

florio® HAEMO: A Longitudinal Survey of Patient Preference, Adherence and Wearable Functionality in Central Europe

Advances in therapy, 2024-07, Vol.41 (7), p.2791-2807

2024

Volltextzugriff (PDF)

Treatment of Adults and Young Adults with Acute Lymphoblastic Leukemia: Real Life Data from Two Centers in Slovakia

Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21 (10), p.e782-e791

2021

Volltextzugriff (PDF)

Effectiveness of Lenalidomide and Dexamethasone for the Treatment of Extramedullary Plasmacytoma in Patients with Multiple Myeloma: Report of Two Cases

Blood, 2014-12, Vol.124 (21), p.5760-5760

2014

Volltextzugriff (PDF)

P1620: A CROSS‐NATIONAL SURVEY OF PEOPLE LIVING WITH HEMOPHILIA: REPORTED PAIN, IMPACT ON PHYSICAL ACTIVITY AND OPPORTUNITY ON USING DIGITAL TOOLS FOR MONITORING HAEMOPHILIA

HemaSphere, 2023-08, Vol.7 (S3), p.e183378c-n/a

2023

Volltextzugriff (PDF)

P1630: A 2022 CROSS‐NATIONAL SURVEY OF PEOPLE LIVING WITH HAEMOPHILIA DURING THE COVID‐19 PANDEMIC: VIEWS ON VACCINATION‐ AND INFECTION‐RELATED RISKS

HemaSphere, 2023-08, Vol.7 (S3), p.e10095d7-n/a

2023

Volltextzugriff (PDF)

Expert opinion on current and future prophylaxis therapies aimed at improving protection for people with hemophilia A

Journal of medicine and life, 2022-04, Vol.15 (4), p.570-578

2022

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Englisch
(67)
Tschechisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab

Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation – the surgical STER

Rare bleeding disorders

Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test

Analysis of von Willebrand Disease in the “Heart of Europe”

Comparison of Two Different Techniques Of Warfarin Dosing Determination - A Chemometrics Study

The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones

First experience of a hemophilia monitoring platform: florio HAEMO

Continuous infusion of coagulation factors: current opinion

Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus

First case report on persistent patellar dislocation in haemophilia A patient with a factor VIII inhibitor

Evaluation of factor V mRNA to define the residual factor V expression levels in severe factor V deficiency

Real-World Early Treatment with Room Temperature–Stable Recombinant Factor VIIa in Hemophilia A/B and Inhibitors: SMART-7™ Post Hoc Analyses

ASP210: a potent oligonucleotide-based inhibitor effective against TKI-resistant CML cells

Real-world effectiveness and safety of daratumumab, bortezomib and dexamethasone in relapsed/refractory multiple myeloma in Slovakia

ASP210 - a Potent Oligonucleotide-Based Inhibitor for Combating Both BCR-ABL1 Dependent and Independent TKI-Resistant CML Cells

Are all licensed haemostatic agents for haemophilia therapy accessible to patients?

Allogeneic hematopoietic stem cell transplantation from matched related donors for acute myeloid leukemia

Immune tolerance induction in the era of emicizumab – still the first choice for patients with haemophilia A and inhibitors?

florio® HAEMO: A Longitudinal Survey of Patient Preference, Adherence and Wearable Functionality in Central Europe

Treatment of Adults and Young Adults with Acute Lymphoblastic Leukemia: Real Life Data from Two Centers in Slovakia

Effectiveness of Lenalidomide and Dexamethasone for the Treatment of Extramedullary Plasmacytoma in Patients with Multiple Myeloma: Report of Two Cases

P1620: A CROSS‐NATIONAL SURVEY OF PEOPLE LIVING WITH HEMOPHILIA: REPORTED PAIN, IMPACT ON PHYSICAL ACTIVITY AND OPPORTUNITY ON USING DIGITAL TOOLS FOR MONITORING HAEMOPHILIA

P1630: A 2022 CROSS‐NATIONAL SURVEY OF PEOPLE LIVING WITH HAEMOPHILIA DURING THE COVID‐19 PANDEMIC: VIEWS ON VACCINATION‐ AND INFECTION‐RELATED RISKS

Expert opinion on current and future prophylaxis therapies aimed at improving protection for people with hemophilia A

Suchergebnisse filtern